Suzetrigine as a novel treatment for headache disorders: A case series
Headache: The Journal of Head and Face Pain · 2026-07 · 66 (7) · 1644-1649
DOI: 10.1111/head.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Headache: The Journal of Head and Face Pain, online erschienen am 05.06.2026. Verfasst von Molly Fensterwald und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Goldberg Migraine Program, University of California Los Angeles, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Headache Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wendy and Leonard Goldberg Endowment, NCATS NIH HHS.
Abstract (Originalsprache)
Suzetrigine is a selective voltage‐gated sodium channel blocker that was recently approved by the US Food and Drug Administration for the treatment of acute pain. We retrospectively evaluated the efficacy and tolerability of suzetrigine for the treatment of different headache disorders in patients refractory to standard treatments in an academic headache center. These patients had a variety of headache and facial pain diagnoses, including chronic migraine, medication‐overuse headache, trigeminal autonomic cephalalgias, nummular headache, occipital neuralgia, and persistent idiopathic facial pain. Some did not clearly meet any diagnostic criteria. The treatment was generally well tolerated, and most patients reported improvement as measured by patient global impression of change. Suzetrigine is a promising new therapeutic approach that warrants further study for the treatment of headache disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Goldberg Migraine Program, University of California Los Angeles, Los Angeles, California, USA.
Förderung
- Wendy and Leonard Goldberg Endowment
- NCATS NIH HHS
Zitieren
APA
Fensterwald, M., Johnson, J., Moreno, A., Conger-Love, S., Flippen, C., Hesterman, C., Johnston, M., Kamins, J., Minota, K., Pak, P., Hashim, S., Huynh-Tran, T. L., Kobayashi, N., Shane, B., Charles, A., & Nwaobi, S. (2026). Suzetrigine as a novel treatment for headache disorders: A case series. Headache: The Journal of Head and Face Pain, 66(7), 1644-1649. https://doi.org/10.1111/head.70147
Vancouver
Fensterwald M, Johnson J, Moreno A, Conger-Love S, Flippen C, Hesterman C, et al. Suzetrigine as a novel treatment for headache disorders: A case series. Headache: The Journal of Head and Face Pain. 2026;66(7):1644-1649. doi:10.1111/head.70147
BibTeX
@article{Fensterwald2026,
author = {Fensterwald, Molly and Johnson, Jordan and Moreno, Angel and Conger-Love, Shawn and Flippen, Charles and Hesterman, Chelsea and Johnston, Mollie and Kamins, Joshua and Minota, Karla and Pak, Peony and Hashim, Salman and Huynh-Tran, Thanh-Liem and Kobayashi, Noelle and Shane, Bradley and Charles, Andrew and Nwaobi, Sinifunanya},
title = {Suzetrigine as a novel treatment for headache disorders: A case series},
journal = {Headache: The Journal of Head and Face Pain},
year = {2026},
volume = {66},
number = {7},
pages = {1644--1649},
doi = {10.1111/head.70147}
}
EUVIMED